APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Rabies Vaccine (Vero Cell)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Rabies Vaccine (Vero Cell) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174000070322 December 2025190 pages

Choose your research edition.

Industry ResearchHuman Rabies Vaccine (Vero Cell) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rabies Vaccine (Vero Cell) Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Human Rabies Vaccine (Vero Cell) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rabies Vaccine (Vero Cell) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rabies Vaccine (Vero Cell) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Human Rabies Vaccine (Vero Cell) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Rabies Vaccine (Vero Cell) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Rabies Vaccine (Vero Cell) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Rabies Vaccine (Vero Cell) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Rabies Vaccine (Vero Cell) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Rabies Vaccine (Vero Cell) include Changchun Zhuoyi Biology, Ningbo Rong'an, Liaoning Chengda, Jilin Huikang Biopharmaceutical Co., Ltd., Hualan Bio-vaccine, Guangzhou Nuocheng, Dalian Yali Peak, Chengdu Kanghua Biology and Serum Institute of India Pvt., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Rabies Vaccine (Vero Cell) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Rabies Vaccine (Vero Cell) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Rabies Vaccine (Vero Cell) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Rabies Vaccine (Vero Cell) market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Rabies Vaccine (Vero Cell) Segment by Company

Changchun Zhuoyi Biology

Ningbo Rong'an

Liaoning Chengda

Jilin Huikang Biopharmaceutical Co., Ltd.

Hualan Bio-vaccine

Guangzhou Nuocheng

Dalian Yali Peak

Chengdu Kanghua Biology

Serum Institute of India Pvt.

Sanofi Pasteur SA

Bharat Biotech

Bavarian Nordic

Human Rabies Vaccine (Vero Cell) Segment by Type

0.5ml

1ml

Human Rabies Vaccine (Vero Cell) Segment by Application

Hospital

Clinic

Human Rabies Vaccine (Vero Cell) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Vaccine (Vero Cell) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Vaccine (Vero Cell) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Vaccine (Vero Cell).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Rabies Vaccine (Vero Cell) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Rabies Vaccine (Vero Cell) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Rabies Vaccine (Vero Cell) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Rabies Vaccine (Vero Cell) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Rabies Vaccine (Vero Cell) Industry Trends Table 2. Human Rabies Vaccine (Vero Cell) Industry Drivers Table 3. Human Rabies Vaccine (Vero Cell) Industry Opportunities and Challenges Table 4. Human Rabies Vaccine (Vero Cell) Industry Restraints Table 5. Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Rabies Vaccine (Vero Cell) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Manufacturers Table 9. Global Human Rabies Vaccine (Vero Cell) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Human Rabies Vaccine (Vero Cell) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Rabies Vaccine (Vero Cell) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Rabies Vaccine (Vero Cell) Manufacturers, Product Type & Application Table 13. Global Human Rabies Vaccine (Vero Cell) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Rabies Vaccine (Vero Cell) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.5ml Table 17. Major Manufacturers of 1ml Table 18. Global Human Rabies Vaccine (Vero Cell) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2026) & (k units) Table 20. Global Human Rabies Vaccine (Vero Cell) Sales by Type (2027-2032) & (k units) Table 21. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2021-2026) Table 22. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2027-2032) Table 23. Global Human Rabies Vaccine (Vero Cell) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2026) & (k units) Table 25. Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2027-2032) & (k units) Table 26. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2021-2026) Table 27. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Human Rabies Vaccine (Vero Cell) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2026) & (k units) Table 32. Global Human Rabies Vaccine (Vero Cell) Sales by Application (2027-2032) & (k units) Table 33. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2021-2026) Table 34. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2027-2032) Table 35. Global Human Rabies Vaccine (Vero Cell) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2026) & (k units) Table 37. Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2027-2032) & (k units) Table 38. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2021-2026) Table 39. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2027-2032) Table 40. Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Human Rabies Vaccine (Vero Cell) Sales by Region (2021-2026) & (k units) Table 42. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Region (2021-2026) Table 43. Global Human Rabies Vaccine (Vero Cell) Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Human Rabies Vaccine (Vero Cell) Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Human Rabies Vaccine (Vero Cell) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2026) & (k units) Table 47. North America Human Rabies Vaccine (Vero Cell) Sales by Country (2027-2032) & (k units) Table 48. Europe Human Rabies Vaccine (Vero Cell) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2026) & (k units) Table 50. Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Human Rabies Vaccine (Vero Cell) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Human Rabies Vaccine (Vero Cell) Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2027-2032) & (k units) Table 57. Global Human Rabies Vaccine (Vero Cell) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2021-2026) Table 61. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2027-2032) Table 62. Changchun Zhuoyi Biology Company Information Table 63. Changchun Zhuoyi Biology Business Overview Table 64. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolio Table 66. Changchun Zhuoyi Biology Recent Development Table 67. Ningbo Rong'an Company Information Table 68. Ningbo Rong'an Business Overview Table 69. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolio Table 71. Ningbo Rong'an Recent Development Table 72. Liaoning Chengda Company Information Table 73. Liaoning Chengda Business Overview Table 74. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolio Table 76. Liaoning Chengda Recent Development Table 77. Jilin Huikang Biopharmaceutical Co., Ltd. Company Information Table 78. Jilin Huikang Biopharmaceutical Co., Ltd. Business Overview Table 79. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolio Table 81. Jilin Huikang Biopharmaceutical Co., Ltd. Recent Development Table 82. Hualan Bio-vaccine Company Information Table 83. Hualan Bio-vaccine Business Overview Table 84. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolio Table 86. Hualan Bio-vaccine Recent Development Table 87. Guangzhou Nuocheng Company Information Table 88. Guangzhou Nuocheng Business Overview Table 89. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolio Table 91. Guangzhou Nuocheng Recent Development Table 92. Dalian Yali Peak Company Information Table 93. Dalian Yali Peak Business Overview Table 94. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolio Table 96. Dalian Yali Peak Recent Development Table 97. Chengdu Kanghua Biology Company Information Table 98. Chengdu Kanghua Biology Business Overview Table 99. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolio Table 101. Chengdu Kanghua Biology Recent Development Table 102. Serum Institute of India Pvt. Company Information Table 103. Serum Institute of India Pvt. Business Overview Table 104. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolio Table 106. Serum Institute of India Pvt. Recent Development Table 107. Sanofi Pasteur SA Company Information Table 108. Sanofi Pasteur SA Business Overview Table 109. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolio Table 111. Sanofi Pasteur SA Recent Development Table 112. Bharat Biotech Company Information Table 113. Bharat Biotech Business Overview Table 114. Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolio Table 116. Bharat Biotech Recent Development Table 117. Bavarian Nordic Company Information Table 118. Bavarian Nordic Business Overview Table 119. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolio Table 121. Bavarian Nordic Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Human Rabies Vaccine (Vero Cell) Distributors List Table 125. Human Rabies Vaccine (Vero Cell) Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Human Rabies Vaccine (Vero Cell) Product Image Figure 2. Global Human Rabies Vaccine (Vero Cell) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Rabies Vaccine (Vero Cell) Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Rabies Vaccine (Vero Cell) Sales (2021-2032) & (k units) Figure 5. Global Human Rabies Vaccine (Vero Cell) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Rabies Vaccine (Vero Cell) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.5ml Image Figure 9. 1ml Image Figure 10. Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Human Rabies Vaccine (Vero Cell) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2021-2032) Figure 13. Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Human Rabies Vaccine (Vero Cell) Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2021-2032) Figure 21. Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2021-2032) Figure 24. North America Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2021-2032) Figure 26. U.S. Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2021-2032) Figure 31. Germany Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2021-2032) Figure 38. China Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales Market Share by Country (2021-2032) Figure 46. Brazil Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Human Rabies Vaccine (Vero Cell) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Human Rabies Vaccine (Vero Cell) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Figure 57. North America Human Rabies Vaccine (Vero Cell) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Figure 59. Europe Human Rabies Vaccine (Vero Cell) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Human Rabies Vaccine (Vero Cell) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Human Rabies Vaccine (Vero Cell) Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Human Rabies Vaccine (Vero Cell) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5ml
  • 1ml
Applications
  • Hospital
  • Clinic
Companies covered
  • Changchun Zhuoyi Biology
  • Ningbo Rong'an
  • Liaoning Chengda
  • Jilin Huikang Biopharmaceutical Co., Ltd.
  • Hualan Bio-vaccine
  • Guangzhou Nuocheng
  • Dalian Yali Peak
  • Chengdu Kanghua Biology
  • Serum Institute of India Pvt.
  • Sanofi Pasteur SA
  • Bharat Biotech
  • Bavarian Nordic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Rabies Vaccine (Vero Cell) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Rabies Vaccine (Vero Cell) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Rabies Vaccine (Vero Cell) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Rabies Vaccine (Vero Cell) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Rabies Vaccine (Vero Cell) Market Dynamics
  1. 2.1 Human Rabies Vaccine (Vero Cell) Industry Trends
  2. 2.2 Human Rabies Vaccine (Vero Cell) Industry Drivers
  3. 2.3 Human Rabies Vaccine (Vero Cell) Industry Opportunities and Challenges
  4. 2.4 Human Rabies Vaccine (Vero Cell) Industry Restraints
3 Human Rabies Vaccine (Vero Cell) Market by Manufacturers
  1. 3.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Rabies Vaccine (Vero Cell) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Rabies Vaccine (Vero Cell) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Rabies Vaccine (Vero Cell) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Rabies Vaccine (Vero Cell) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Rabies Vaccine (Vero Cell) Manufacturers, Product Type & Application
  7. 3.7 Global Human Rabies Vaccine (Vero Cell) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Rabies Vaccine (Vero Cell) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Rabies Vaccine (Vero Cell) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Rabies Vaccine (Vero Cell) Tier 1, Tier 2, and Tier 3
4 Human Rabies Vaccine (Vero Cell) Market by Type
  1. 4.1 Human Rabies Vaccine (Vero Cell) Type Introduction
  2. 4.1.1 0.5ml
  3. 4.1.2 1ml
  4. 4.2 Global Human Rabies Vaccine (Vero Cell) Sales by Type
  5. 4.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Human Rabies Vaccine (Vero Cell) Sales by Type (2021-2032)
  7. 4.2.3 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Human Rabies Vaccine (Vero Cell) Revenue by Type
  9. 4.3.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Type (2021-2032)
  11. 4.3.3 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Type (2021-2032)
5 Human Rabies Vaccine (Vero Cell) Market by Application
  1. 5.1 Human Rabies Vaccine (Vero Cell) Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Human Rabies Vaccine (Vero Cell) Sales by Application
  5. 5.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Human Rabies Vaccine (Vero Cell) Sales by Application (2021-2032)
  7. 5.2.3 Global Human Rabies Vaccine (Vero Cell) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Human Rabies Vaccine (Vero Cell) Revenue by Application
  9. 5.3.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Application (2021-2032)
  11. 5.3.3 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Application (2021-2032)
6 Global Human Rabies Vaccine (Vero Cell) Sales by Region
  1. 6.1 Global Human Rabies Vaccine (Vero Cell) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Rabies Vaccine (Vero Cell) Sales by Region (2021-2032)
  3. 6.2.1 Global Human Rabies Vaccine (Vero Cell) Sales by Region (2021-2026)
  4. 6.2.2 Global Human Rabies Vaccine (Vero Cell) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Rabies Vaccine (Vero Cell) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Rabies Vaccine (Vero Cell) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Rabies Vaccine (Vero Cell) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Rabies Vaccine (Vero Cell) Revenue by Region
  1. 7.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Region
  2. 7.1.1 Global Human Rabies Vaccine (Vero Cell) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Rabies Vaccine (Vero Cell) Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Rabies Vaccine (Vero Cell) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Rabies Vaccine (Vero Cell) Revenue (2021-2032)
  8. 7.2.2 North America Human Rabies Vaccine (Vero Cell) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Rabies Vaccine (Vero Cell) Revenue (2021-2032)
  11. 7.3.2 Europe Human Rabies Vaccine (Vero Cell) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Rabies Vaccine (Vero Cell) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Rabies Vaccine (Vero Cell) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Rabies Vaccine (Vero Cell) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Changchun Zhuoyi Biology
  2. 8.1.1 Changchun Zhuoyi Biology Company Information
  3. 8.1.2 Changchun Zhuoyi Biology Business Overview
  4. 8.1.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product Portfolio
  6. 8.1.5 Changchun Zhuoyi Biology Recent Developments
  7. 8.2 Ningbo Rong'an
  8. 8.2.1 Ningbo Rong'an Company Information
  9. 8.2.2 Ningbo Rong'an Business Overview
  10. 8.2.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product Portfolio
  12. 8.2.5 Ningbo Rong'an Recent Developments
  13. 8.3 Liaoning Chengda
  14. 8.3.1 Liaoning Chengda Company Information
  15. 8.3.2 Liaoning Chengda Business Overview
  16. 8.3.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product Portfolio
  18. 8.3.5 Liaoning Chengda Recent Developments
  19. 8.4 Jilin Huikang Biopharmaceutical Co., Ltd.
  20. 8.4.1 Jilin Huikang Biopharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Jilin Huikang Biopharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product Portfolio
  24. 8.4.5 Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Hualan Bio-vaccine
  26. 8.5.1 Hualan Bio-vaccine Company Information
  27. 8.5.2 Hualan Bio-vaccine Business Overview
  28. 8.5.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product Portfolio
  30. 8.5.5 Hualan Bio-vaccine Recent Developments
  31. 8.6 Guangzhou Nuocheng
  32. 8.6.1 Guangzhou Nuocheng Company Information
  33. 8.6.2 Guangzhou Nuocheng Business Overview
  34. 8.6.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product Portfolio
  36. 8.6.5 Guangzhou Nuocheng Recent Developments
  37. 8.7 Dalian Yali Peak
  38. 8.7.1 Dalian Yali Peak Company Information
  39. 8.7.2 Dalian Yali Peak Business Overview
  40. 8.7.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product Portfolio
  42. 8.7.5 Dalian Yali Peak Recent Developments
  43. 8.8 Chengdu Kanghua Biology
  44. 8.8.1 Chengdu Kanghua Biology Company Information
  45. 8.8.2 Chengdu Kanghua Biology Business Overview
  46. 8.8.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product Portfolio
  48. 8.8.5 Chengdu Kanghua Biology Recent Developments
  49. 8.9 Serum Institute of India Pvt.
  50. 8.9.1 Serum Institute of India Pvt. Company Information
  51. 8.9.2 Serum Institute of India Pvt. Business Overview
  52. 8.9.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product Portfolio
  54. 8.9.5 Serum Institute of India Pvt. Recent Developments
  55. 8.10 Sanofi Pasteur SA
  56. 8.10.1 Sanofi Pasteur SA Company Information
  57. 8.10.2 Sanofi Pasteur SA Business Overview
  58. 8.10.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product Portfolio
  60. 8.10.5 Sanofi Pasteur SA Recent Developments
  61. 8.11 Bharat Biotech
  62. 8.11.1 Bharat Biotech Company Information
  63. 8.11.2 Bharat Biotech Business Overview
  64. 8.11.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product Portfolio
  66. 8.11.5 Bharat Biotech Recent Developments
  67. 8.12 Bavarian Nordic
  68. 8.12.1 Bavarian Nordic Company Information
  69. 8.12.2 Bavarian Nordic Business Overview
  70. 8.12.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product Portfolio
  72. 8.12.5 Bavarian Nordic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Rabies Vaccine (Vero Cell) Value Chain Analysis
  2. 9.1.1 Human Rabies Vaccine (Vero Cell) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Rabies Vaccine (Vero Cell) Production Mode & Process
  6. 9.2 Human Rabies Vaccine (Vero Cell) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Rabies Vaccine (Vero Cell) Distributors
  9. 9.2.3 Human Rabies Vaccine (Vero Cell) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst